Stability of 8 second or third generation cephalosporins in peritoneal dialysis fluid
Grise, G.; Lemeland, J.F.; Fillastre, J.P.
Pathologie-Biologie 33(5): 335-339
1985
ISSN/ISBN: 0369-8114 PMID: 3897963 Document Number: 245773
The main complication of chronic ambulatory peritoneal dialysis is peritoneal infection due to contamination while handling dialysate bags. For this reason antibiotics should be added to the dialysate to prevent infection. Some antibiotics are known to be unstable when dissolved in dialysate. We therefore studied the bactericidal activity of eight second or third generation cephalosporins against Escherichia coli and Staphylococcus aureus under conditions similar to in vivo situations. Comparison of killing curves shows that bactericidal activity is unchanged after 24 hours in the dialysis fluid at room temperature.
Document emailed within 1 workday
Related Documents
Oba, I.; Mori, T.; Chida, M.; Kurasawa, N.; Naganuma, E.; Sato, E.; Koizumi, K.; Sato, S.; Tsuchikawa, M.; Ito, S. 2015: Glucose and Insulin Response to Peritoneal Dialysis Fluid in Diabetic and Nondiabetic Peritoneal Dialysis Patients Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 31: 11-16Esteve, V.; Ponz, E.; Marquina, D.; Blasco, C.; Martínez Ocaña, J.C.; Mañé, N.; García, M. 2006: Peritoneal fluid agitation and dialysis dose estimation in automatic peritoneal dialysis Nefrologia: Publicacion Oficial de la Sociedad Espanola Nefrologia 26(2): 267-269
Benaroia, M.; Morton, A.R.; Cheeseman, F.D.; Garland, J.S.; Toffelmire, E.B. 2008: Spontaneous peritoneal membrane rupture with extravasation of peritoneal fluid into the lower limbs and flank in a peritoneal dialysis patient Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 28(5): 554-557
De Santo, N.G.; Capodisaca, G.; Senatore, R.; Cicchetti, T.; Cirillo, D.; Damiano, M.; Giordano, C. 1979: Stability of peritoneal urea clearance in continuous ambulatory peritoneal dialysis (18 months experience with CAPD) International Journal of Artificial Organs 2(4): 193-196
De Fijter, C.W.; Verbrugh, H.A.; Oe, P.L.; Peters, E.D.; van der Meulen, J.; Donker, A.J.; Verhoef, J.; Lameire, N. 1991: The effect of glycerol-containing peritoneal dialysis fluid on peritoneal macrophage function in vivo Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 7: 154-157
Zweers, M.M.; Splint, L.J.; Krediet, R.T.; Struijk, D.G. 2001: Effect of fluid supplementation and modality on peritoneal permeability characteristics in a rat peritoneal dialysis model Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 21(1): 58-64
Moberly, J.B.; Sorkin, M.; Kucharski, A.; Ogle, K.; Mongoven, J.; Skoufos, L.; Lin, L.; Bailey, S.; Rodela, H.; Mupas, L.; Walele, A.; Ogrinc, F.; White, D.; Wolfson, M.; Martis, L.; Breborowicz, A.; Oreopoulos, D.G. 2003: Effects of intraperitoneal hyaluronan on peritoneal fluid and solute transport in peritoneal dialysis patients Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(1): 63-73
Duan, S.; Liu, F.; Xiao, P.; Xia, J.; Peng, Y.; Ye, Y.; Luo, J. 2001: The effect of lactate-buffered peritoneal dialysis fluid in human peritoneal mesothelial cells function Zhonghua Nei Ke Za Zhi 40(7): 463-466
Ogata, S.; Yorioka, N.; Kiribayashi, K.; Naito, T.; Kuratsune, M.; Nishida, Y. 2003: Viability of, and basic fibroblast growth factor secretion by, human peritoneal mesothelial cells cultured with various components of peritoneal dialysis fluid Advances in Peritoneal Dialysis. Conference on Peritoneal Dialysis 19: 2-5
Mawhinney, W.M.; Adair, C.G.; Gorman, S.P.; McClurg, B. 1992: Stability of ciprofloxacin in peritoneal dialysis solution American Journal of Hospital Pharmacy 49(12): 2956-2959
Paap, C.M.; Nahata, M.C. 1990: Stability of cefotaxime in two peritoneal dialysis solutions American Journal of Hospital Pharmacy 47(1): 147-150
Cueto-Manzano, A.M.; Rojas-Campos, E.; Martínez-Ramírez, H.éc.R.; Valera-González, I.; Medina, M.; Monteón, F.; Ruiz, N.; Becerra, M.; Palomeque, M.A.; Cortés-Sanabria, L. 2006: Can the inflammation markers of patients with high peritoneal permeability on continuous ambulatory peritoneal dialysis be reduced on nocturnal intermittent peritoneal dialysis? Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 26(3): 341-348
Dooley, D.P.; Tyler, J.R.; Wortham, W.G.; Harrison, L.S.; Starnes, W.F.; Collins, G.R.; Ozuna, I.S.; Violet, P.L.; Ward, J.A. 2003: Prolonged stability of antimicrobial activity in peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(1): 58-62
Manley, H.J.; Grabe, D.W.; Norcross, M.; Cooperman, T.A.; Stinchcomb, A.L.; Hass, M.; Bailie, G.R. 2000: Stability of amphotericin B-lipid complex (Abelcet) in peritoneal dialysis solutions Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 20(1): 87-90
Manuprasert, W.; Kanchanabuch, S.; Eiam-Ong, S.; Kanjanabuch, T. 2011: The in vitro toxicity of peritoneal dialysis fluid Journal of the Medical Association of Thailand 94(Suppl 4): S140-S147
Kenny, M.T.; Dulworth, J.K.; Brackman, M.A. 1989: Bioassay for teicoplanin in peritoneal dialysis fluid Drugs under Experimental and Clinical Research 15(11-12): 549-552
Arbeiter, K.; Bidmon, B.; Endemann, M.; Ruffingshofer, D.; Mueller, T.; Regele, H.; Eickelberg, O.; Aufricht, C. 2003: Induction of mesothelial HSP-72 upon in vivo exposure to peritoneal dialysis fluid Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 23(5): 499-501
Weryński, A.; Lindholm, B. 2006: The kinetic analysis of sodium and fluid transport in peritoneal dialysis Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 21(122): 182-186; Discussion 187
Cusumano, A.M.; Poratto, F.; del Pino, N.í; Fernández, J.é L.; Vilches, A. 2005: Identification of hepatitis C virus RNA in peritoneal dialysis fluid of patients with viremia Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis 25(5): 478-482
Pietrzak, I.; Baczyk, K.; Ksiazek, P. 1995: Thiamine blood level and erythrocyte transketolase activity in continuous ambulatory peritoneal dialysis and intermittent peritoneal dialysis patients Annales Universitatis Mariae Curie-Sklodowska. Sectio D: Medicina 50: 197-203